ANGIOGENESIS

Scope & Guideline

Advancing Knowledge in Tumor Biology and Tissue Regeneration

Introduction

Immerse yourself in the scholarly insights of ANGIOGENESIS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0969-6970
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1997 to 1999, from 2001 to 2024
AbbreviationANGIOGENESIS / Angiogenesis
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'ANGIOGENESIS' is dedicated to advancing the understanding of angiogenesis and its role in various biological processes and diseases. It focuses on the molecular, cellular, and physiological aspects of angiogenesis, providing a platform for research that explores the mechanisms and therapeutic implications of vascular development and dysfunction.
  1. Molecular Mechanisms of Angiogenesis:
    Research that elucidates the molecular pathways and signaling cascades involved in angiogenesis, including factors like VEGF, angiopoietins, and various growth factors.
  2. Endothelial Cell Biology:
    Studies focusing on endothelial cell function, plasticity, and interactions in health and disease, particularly in the context of vascular development and pathology.
  3. Pathological Angiogenesis:
    Exploration of abnormal angiogenesis in diseases such as cancer, diabetic retinopathy, and hereditary hemorrhagic telangiectasia, highlighting potential therapeutic targets.
  4. Vascular Development and Regeneration:
    Research on the processes of vasculogenesis and angiogenesis during development and tissue repair, including the role of stem cells and tissue engineering.
  5. Clinical Applications and Therapeutics:
    Studies that translate basic research findings into clinical applications, focusing on novel therapies for conditions associated with aberrant angiogenesis.
  6. Inflammation and Angiogenesis:
    Investigations into how inflammatory processes influence angiogenic responses, particularly in the context of chronic diseases and infections.
The journal 'ANGIOGENESIS' has recently witnessed a surge in interest in several innovative and emerging themes. These trends reflect the evolving landscape of research in vascular biology and highlight areas of significant clinical relevance.
  1. Angiogenesis in COVID-19 and Post-Viral Syndromes:
    Research addressing the role of angiogenesis in COVID-19 and its long-term effects, including complications like post-COVID syndrome and microvascular dysfunction.
  2. Mitochondrial Dysfunction and Angiogenesis:
    An increasing number of studies are exploring the interplay between mitochondrial function and angiogenesis, particularly in pathological conditions such as diabetic retinopathy.
  3. Utilization of iPSC-Derived Endothelial Cells:
    The use of induced pluripotent stem cells (iPSCs) to study endothelial cell behavior and disease mechanisms is gaining momentum, providing insights into vascular development and regeneration.
  4. Role of Extracellular Vesicles in Angiogenesis:
    Emerging research on the role of extracellular vesicles and small RNAs in modulating angiogenic processes, particularly in cancer and inflammatory diseases.
  5. Mechanobiology of Endothelial Cells:
    A growing interest in how mechanical forces and the physical properties of the vascular microenvironment influence endothelial cell behavior and angiogenesis.
  6. Targeted Therapeutics in Cancer Angiogenesis:
    A trend towards the development of targeted therapies that specifically inhibit angiogenesis in tumor microenvironments, reflecting the need for precision medicine in oncology.

Declining or Waning

While 'ANGIOGENESIS' has consistently focused on various aspects of vascular biology, certain themes have seen a decline in emphasis over recent years. This may reflect shifts in research priorities or the maturation of specific areas within the field.
  1. Traditional Angiogenesis Models:
    There has been a noticeable decrease in studies relying solely on classical in vitro angiogenesis assays, as newer technologies and models like organ-on-a-chip systems gain traction.
  2. Generalized Anti-Angiogenic Therapies:
    Research focusing on broad-spectrum anti-angiogenic therapies has waned, with a shift towards more targeted and personalized approaches in specific diseases.
  3. Static Analysis of Endothelial Cells:
    The focus on static, non-dynamic analyses of endothelial cells has declined, giving way to more dynamic studies that incorporate mechanical forces and cellular interactions.
  4. Non-Specific Biomarker Studies:
    There has been a reduction in publications centered on generic biomarkers for angiogenesis, as more specific and mechanistic approaches are favored.
  5. Angiogenesis in Non-Pathological Contexts:
    Less emphasis is placed on studying angiogenesis in normal physiological contexts, with a stronger focus on pathological conditions and their therapeutic implications.

Similar Journals

DEVELOPMENT

Fostering a deeper understanding of life’s developmental mechanisms.
Publisher: COMPANY BIOLOGISTS LTDISSN: 0950-1991Frequency: 24 issues/year

DEVELOPMENT is a preeminent journal published by COMPANY BIOLOGISTS LTD, headquartered in the United Kingdom. With an ISSN of 0950-1991 and an E-ISSN of 1477-9129, this esteemed journal has been at the forefront of the fields of Developmental Biology and Molecular Biology since its inception in 1987. Recognized for its rigorous peer review process and high-caliber research, DEVELOPMENT holds an impressive Q1 ranking in both disciplines as of 2023, underscoring its pivotal role in advancing scientific understanding. The journal is particularly noted for its contributions to the understanding of developmental processes, their molecular underpinnings, and their implications in health and disease. With a significant impact factor, DEVELOPMENT aims to disseminate groundbreaking research that inspires novel insights and future explorations within the biological sciences, making it an essential resource for researchers, professionals, and students alike. The journal also maintains accessibility for its readership, ensuring that significant research findings reach those who can apply and build upon them.

Cell Stem Cell

Advancing the Frontiers of Stem Cell Research
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

GENESIS

Exploring Breakthroughs in Medicine and Genetics
Publisher: WILEYISSN: 1526-954XFrequency: 12 issues/year

GENESIS is a renowned journal dedicated to advancing the fields of Cell Biology, Endocrinology, Genetics, and Miscellaneous Medicine, published by WILEY. With an ISSN of 1526-954X and an E-ISSN of 1526-968X, this journal has established a significant presence in academic publishing since its inception in 2000. Positioned within the Q3 category for Cell Biology and Q2 categories for Endocrinology, Genetics, and Medicine in the 2023 rankings, GENESIS offers an interdisciplinary platform that fosters pioneering research and innovation. Additionally, the journal provides options for Open Access, ensuring that vital discoveries are accessible to a broader audience. Researchers, professionals, and students alike will find valuable insights and cutting-edge studies within its pages, making GENESIS a crucial resource for anyone invested in the biological sciences.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Connecting Scientists to Transform Pathological Understanding
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

CELL BIOCHEMISTRY AND FUNCTION

Fostering Collaboration in Biochemistry and Cell Biology
Publisher: WILEYISSN: 0263-6484Frequency: 8 issues/year

CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

CELL AND TISSUE RESEARCH

Elevating Understanding of Tissues and Cells Since 1924
Publisher: SPRINGERISSN: 0302-766XFrequency: 12 issues/year

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

Inflammation and Regeneration

Advancing the frontiers of immunology and regenerative medicine.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

INTERNATIONAL ANGIOLOGY

Fostering Discourse on the Latest in Vascular Research
Publisher: EDIZIONI MINERVA MEDICAISSN: 0392-9590Frequency: 6 issues/year

INTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.

Journal of Developmental Biology

Bridging Knowledge Across Biological Systems
Publisher: MDPIISSN: Frequency: 4 issues/year

Journal of Developmental Biology, published by MDPI, is an esteemed open access journal that has been contributing to the field since its inception in 2013. With a focus on developmental processes across various biological systems, this journal serves as a vital platform for disseminating cutting-edge research and fostering dialogue among experts in the fields of Cell Biology, Developmental Biology, and Molecular Biology. The journal currently holds a commendable Q2 ranking in both Developmental Biology and Molecular Biology, underscoring its significance in advancing knowledge within these domains. Operating out of Switzerland, and featuring an engaging array of articles, the journal prioritizes accessibility through its Open Access model, further expanding the reach of vital research findings. Whether you are a seasoned researcher or an enthusiastic student, the Journal of Developmental Biology provides an essential resource for the latest insights and developments in this rapidly evolving field.

Cells & Development

Advancing the Frontiers of Developmental Biology
Publisher: ELSEVIERISSN: 2667-2901Frequency: 4 issues/year

Cells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.